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Abstract 
         Hepatitis is a viral disease; it has a wide distribution among peoples in different countries' and it has 
more than five common types named; A, B, C, D and E. The serum level of total protein, albumin and 
ferritin was estimated in patients with chronic hepatitis B and C, in male and female aged from 19 – 50 
years; at the same time same variance was measured in apparently normal healthy volunteers. A patient 
with other liver disease was excluded from this search.  
      The average values for total protein, albumin, and ferritin for normal volunteers are (5.33, 4.742 and 
51.458 g/ dl) respectively for male and 5.342, 4.733 and 51.667 g/ dl in the female. While its value in HBV 
was (3.399, 2.878 and 77.909 g/dl) for male and 3.429, 3.092 and 137.091g/dl in female respectively. 
While in HCV, the value for total protein, albumin and ferritin was (4.045, 3.462 and 151.182 g/dl) 
respectively in male and 3.838, 3.391 and 68.167 respectively in the female. Using statistical analysis, the 
results indicate that there is a significant value for all variances when compared with the control in both 
cases B and C. The p-value was highly significant its value in HBV male patients is 6.4E-19, 5.11E-17 and 
1.96E-12 for total protein, albumin and ferritin respectively and 1.6E-18, 2.03E-15 and 3.65E-24 for 
female. While in type HCV male patients the p- values were 8.01E-10, 1.9E-10 and 5.13E-17 for total 
protein, albumin and ferritin respectively, in female the values are 1.79E-16, 3.36E-12 and 1.78E-05 
respectively. The results indicate also a positive correlation between all of the variance in the two types of 
patients. 
Keywords: chronic hepatitis, B, chronic hepatitis, C, total protein, albumin,and ferritin.     
ةصلاخلا 
 , يد , يس , يب , يأ 5 يه  عاونأ ةسمخ نم رثكا هل فرعتو , ملاعلا لود مظعم يف راشتنلاا ةعساو ضارملاا نم يسوريافلا دبكلا باهتلا
يس نيعونمل مئادلا يسوريافلا دبكلا باهتلاب نيباصملا ىضرملا لاصما يف نيترفلاو نيموبللاا , ةيمكلا تانيتوربلا ىوتسم سايق مت .يأ و  و
ل يب نم هيرمعلا تائفملو ءاسنلاو لاجرلا نيسنجلا لاك94  ىلا05  ةعومجم مهرابتعلا ءاحصا نيعوطتم نم مد ذخا مت تقولا سفنبو ,هنس
 .ثحبلا اذه يف هفمتخملا دبكلا ضارماب نيباصملا ىضرملا عيمج لامها مت دقو .ةرطيس 
صلاا مد يف نيترفلاو نيموبللاا , يمكلا نيتوربلا نم لك ميق لدعم دودحب تناك روكذلا ءاح0.55  ,4.2.4  و ,09.430  .يلاوتلا ىمع
 ءاسنلا يف تاريغتملا سفن ميق تناك نيح يف0.54. ,4.255 و09.112  دبكلا باهتلا ىضرم يف ميقلا تناك نيح يف يلاوتلا ىمع
 دودحب لاجرمل يب عون يسوريافلا5.544 ,..323  و22.454  ءاسنلا ىضرملا يف اما يلاوتلا ىمع دودحب تناكف5.4.4  ,5.54.  و
952.549  روكذلا ىضرممل ميقلا تناك يس عونلا ىضرم يفو . يلاوتلا ىمع4.540 ,5.41.  و909.93.  ءاسنملو5.353  ,5.549 
 و13.912  .يلاوتلا ىمع نيترفلاو نيموبللااو يمكلا نيتوربلا نم لكل 
 رادصلإا ءاصحلإا جمانرب مادختسا مت93 أ جئاتنلا ليمحتل لاكلو اهسايق مت يتلا تاريغتملا عيمج يف هيونعم ميق كانه ناب جئاتنلا تحضو
نلا يفنيترفلاو نيموبللاا , يمكلا نيتوربلا نممكل لاجرلا يف يب عونمل هيونعملا ميقلا تناكو يس و يب يسوريافلا باهتللاا نم نيعونلا يب عو
 دودحب6.4E-195.11E-17, و1.96E-12  ءاسنلا يفو1.6E-18 ,2.03E-1  و3.65E-24  لاجرمل يس عونلا يفو .يلاوتلا ىمع
  هيونعملا ميقلا تناك8.01E-10  ,1.9E-10  و5.13E-17  ءاسنملو1.79E-16 ,3.36E-12  و1.78E-05  سفنل يلاوتلا ىمع
هساردلا اهتممش يتلا تاريغتملا عيمج نيب هبجوم هيطبارت هقلاع كانه نا ظحول امك .ةلاعا تاريغتملا لسمست. 
 
لا:ةيحاتفم تاممك .يب ستياتبه ,يس ستياتبه ,يمكلا نيتوربلا , نيموبلا , نيترف 
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Introduction and literature review: 
Hepatitis C virus (HCV) regard as one of the large health care burden in different 
countries in the world. Nearly, 130–170 million living persons are with chronic HCV 
infection [Rodalia M. etal 2014, Global B. 2004], when this disease left without 
treatment, may develop to cancer or cirrhosis of the liver. In Arabic regain 
Egyptrecognize as the greatest burden of HCV infection, about  10% prevalence of 
chronic HCV infection (CHC) among a population with age ranged from 15 to 59 years 
[El-Zanaty etal 2009]. From this percent about 70–80% reported as HCV infections 
persist and about 30% of individuals weredeveloped to severe liver disease, comprising 
hepatocellular carcinoma and cirrhosis [David et al 2002].Variability in theresponse of 
virology depends on diverse patient factors as well as histological and virological factors 
in addition to the interaction between these factors [Feuerstadt et al 2010].These factors 
include age, duration of infection, gender, mode of acquisition, HCV genotype, ethnicity 
the degree of fibrosis of the liver, viral load [Thio & Thomas DL. 2010],and the degree 
iron overload in hepatic [Metwally et al 2004,Fujita et al2007]. 
One of the most proper marker for liver iron deposition is serum ferritin (SF) for 
this reason in addition to a relatively low-cost it has been widely used as noninvasive tool 
to monitor iron status [Tavill, 2001] and can be used as an indirect marker for the 
estimation of hepatic iron concentration, since hepatic iron controls the production of 
serum ferritin (SF) [Knovich , etal 2009].Many researchers have mentioned that, the 
increase of serum ferritin concentration in patients with either, type 2 diabetes, or 
steatosis,and metabolic syndrome [Vari & Forouhi], which are often found in CHC 
patients [Adinolfi et al 2001; Asselah etal 2006]. 
 Patients with chronic infection are asymptomatic or have only mild, nonspecific 
symptoms as long as cirrhosis is not present [Lauer et al., 2001; Merican et al., 1993]. 
Patients with the above symptoms suffered from one or more from these frequent 
complications fatigue, weakness, nausea, myalgia, weight loss, and arthralgia [Lauer et 
al., 2001].The aminotransferase enzyme also can be used for monitoring of chronic 
hepatitis C and B. In case of patients infected with chronic hepatitis B, there are nearly 
400 million cases in the worldwide this number represents nearly10- 20% of the total 
infected patients and about one million died / year because of chronic hepatitis B viral 
infection[McMahon et al., 2005; Custer  et al., 2004]. The differences in age at the time 
of infection, following acute hepatitis B and developed to chronic type proportion 
inversely with age, about 35% of this infection happened in young years (1-5 years old), 
while less than ten percent of adult[WHO, 2011]. Viral hepatitis B can be detected in 
different body fluids and blood such as; saliva,  semen, and nasopharyngeal fluids), there 
are four major modes of transmission of this virus:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
• Abnormal sexual practices. 
• Transmission from mother to her child during the period of pregnancy and at birth 
(perinatal). 
• Blood transfusion. 
• Contact or sharing of infected items through close personal. This mode of transmission 
is seen mainly in early childhood. In low-endemic areas, the highest incidence of HBV 
infection is among teenagers and young adults. 
The sexual transmission is the most common modes in addition tothe transmission 
from unsafe injecting practices [Liaw et al., 2010]. Many papers claimed that viral 
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hepatitis B and viral hepatitis I, have common routes of transmission and endemic areas, 
but viral hepatitis B is about 100 times more infectious[Tarantola et al., 2006]. Other 
papers claimed that about 1/3 of all infected people with viral hepatitis I, have a blood 
marker of past or present viral hepatitis B infection. At higher rates of viral hepatitis B 
/viral hepatitis, I happeninmen who have sex with men (MSM) [Thio et al., 2002]. The 
risk of chronic hepatitis B is greater in congenital and causesuppression of the immune 
system, including HIV infection, and due to usage the suppressant drugs of the immune 
system or chronic hemodialysis [Wang et al., 2010]. 
 30% of the patients with chronic active viral hepatitis B, will progress to liver 
cirrhosis after about 30 years, in about 1/4 of cirrhotic patients with hepatitis B will be 
developed to hepatic decompensation over a five-year period; while about 5–10% will 
develop liver cancer. If the patients were Left untreated, approximately 15% of them will 
die within 5 years due to cirrhosis[Liang TJ. 2009].The total body stored iron usually 
reflect by serum ferritin levels since its secretion into circulation is proportional to the 
amount of cellular iron in the form of cellular ferritin [Finch et al., 1986]. 
 
Experimental part: 
Blood samples: 
Blood samples were collected from patients with chronic hepatitis type B (28 
males and 22 females) and chronic hepatitis type C (30 males and 23 females), with ages 
between 17 and 50 years old for both males and females. In addition, blood samples were 
collected from apparently healthy volunteers (20 males and 20 females), from Marjane 
hospital in IRAQ – Babylon city. After collection, the samples were centrifuged for 15 
minutes at 4000 RPM using Hettich – EBA20 centrifuge, serum was collected in clean 
dried tubes.  
Screening for hepatitis:-   
Serum sample was taken for detection of (HBs –Ag and Anti- HCV antibody) for 
confirmation of hepatitis infection in the case study and for exclusion of hepatitis 
infection in the control group by ELISA- Biotech- ELx50 technique, according to the 
principle and procedure of BIOMERIEUX  Hepanostika, Micro Elisa system [Boseind, 
2011]. 
Single Radial Immunodifusion (SRID):- 
Principle:-    
 Equal volumes of reference sera and sample are added to the wells in agarose gel 
containing monospecific antiserum, the sample diffuses radially through the gel and the 
antigen form precipitation ring with the monospecific antiserum. The result can be 
calculated easily from the table of diameters provided with plates [Biomagreb, 2004]. 
Procedure of SRID:-   
1. All Endo plates, reference, and test sera brought to room temperature. 
2. 5 microliter of serum and control were dispensed into the wells of the plate by 
using a suitable pipette (sample should be mixed gently before use).  
3. The plate Center covered by the wet cotton to avoid affairs dehydration.  
4. The plate was tightly closed and incubated at room temperature (23 +/-2`0C) on 
a level surface for equal or more than 48 hours. 
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5. After incubation, the diameter of each ring measured with 0.1 mm precision 
using a suitable viewer. 
6. The results directly evaluated by using the results of the control samples and a 
reference table that is provided with RID plates [Biomagreb, 2004]. 
7.  
Results and discussion 
The data collected from patients indicate there are decreasing in total protein 
concentration in both male and female with respect to that of control groupsas shown in 
fig -1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig- 1: relationship between total protein value in normal and patients with chronic 
HB 
 
The results also show a decrease in albumin concentration in chronic patients 
compared with normal volunteers (control group), will there be in increasing value in 
ferritin concentration in patient group but the increase in themale is greater than in 
females. This result was in agreeing with many published papers, which indicate there are 
an increase in ferritin concentration and decreased in protein and albumin level in serum 
of patients with hepatitis[Wang and Han, 2010]. 
The statistical study using spss program version 18 to show the correlation between 
the biochemical variance in chronic hepatitis B, it was shown that there is a high 
correlation between total protein and albumin (0.8288) wears there is no significant 
correlation between others. In case of age, the results indicate there is a negative 
correlation between total protein and albumin with age, while there is a positive 
correlation with ferritin. As appear in table –1. 
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Table-1: Correlation between variance in chronic hepatitis (b) patients 
  
Total 
protein  albumin  ferritin Age 
Total 
protein  1       
albumin  0.828885 1     
ferritin 0.254072 0.375496 1   
Age -0.1798 -0.38547 -0.217302443 1 
 
In patients with chronic hepatitis C, almost the same results as in chronic B with the 
exception of the correlation of age with all variance are weakly positive values, as in 
table – 2. 
Table-2: Correlation between variance in hepatitis (c) patients 
 
Total protein  albumin ferritin Age 
Total 
protein 1       
albumin 0.68282295 1     
ferritin 0.09989819 0.1345631 1   
Age -0.31540139 -0.3859691 -0.184882505 1 
 
The correlation between the same variance in normal volunteers the data show a high 
correlation between T- protein and albumin (0.9787), and the low positive correlation 
between other parameters, as in table -3. 
Table-3: Correlation between variance in normal volunteers 
 
 
 
 
 
 
To study the significant(p-value)between the biochemical variables between patients and 
normal, healthy volunteers the results show there is a highly significant value between all 
variables in both chronic hepatitis type B &C, with the exception of age the value was not 
significant with respect to ferritin but in the case of protein and albumin the data reviled a 
high difference in p- values, in hepatitis –B than in C. As appears in table – 4. 
age ferritin albumin T-protein  
   1 T-protein 
  1 0.97876928 Albumin 
 1 0.0436392 0.00539911 Ferritin 
1 0.419690978 0.1232478 0.12873169 Age 
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Table-4: p-value between variance in normal and patient 
Age ferritin albumin t-protein  
0.0911161 2.28816E-06 4.30714E-05 1.11357E-05 HIV-B 
0.079178952 8.30635E-06 0.000475561 0.000141556 HIV-C 
 
To establish the effect of sex on biochemical variance used in this study in patients 
with chronic hepatitis B, a statistical analysis was done to verify p-value, slandered 
deviation and average values, tables – 5,6;the sex has highly effective on ferritin, and to a 
less extent in protein and albumin. 
  
Table – 5: effect of sex on variance in chronic HBV 
for male 
  total protein albumin ferritin 
  N P N P N P 
average 5.333 3.399 4.724 2.878 51.485 77.909 
std 0.696 0.459 0.721 0.562 6.704 14.390 
the p-
value 
 
6.43E-19   5.11E-17   1.96E-12 
 
 
Table – 6: effect of sex on variance in chronic HBV for female 
  total protein albumin ferritin 
  N P N P N P 
 the p-
value 
 
1.6E-18   2.03E-15   3.65E-24 
average 5.342 3.429 4.733 3.092 51.667 137.091 
std 0.696 0.363 0.721 0.343 6.704 20.395 
In case of patients with chronic hepatitis –C, nearly the results were found as in chronic 
hepatitis B, highly significant in ferritin compared with other parameters, tables 7,8. 
 
Table – 7: effect of sex on variance in chronic HCV 
for  male 
 
         t- protein albumin ferritin 
  N P N P N P 
the p-
value  
 
8.01E-10   1.9E-10   5.13E-17 
average 5.333 4.045 4.724 3.462 51.485 151.182 
std 0.696 0.753 0.721 0.627 6.704 36.365 
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Table -8: effect of sex on variance in chronic HCV female 
  total protein albumin ferritin 
  N P N P N P 
 the p-
value 
 
1.79E-16   3.36E-12   1.78E-05 
average 5.342 3.838 4.733 3.391 51.667 68.167 
std 0.676 0.383 0.705 0.649 6.655 19.411 
 
Since albumin is synthesized in the liver, and low serum albumin may be indicative 
of liver failure or diseases such as cirrhosis or chronichepatitis. Hypoalbuminemia can 
also present as part of the nephrotic syndrome, in which protein is lost in the urine due 
to kidney damage. Low albumin levels can be an indicator of 
chronic malnutrition or protein-losing enteropathy [Anderson, 2000]. Our results go 
online with that found by [Sargsyants,2009]. Elevated ferritin level was revealed in 
34,3% of patients, and it was significantly higher in men than in women (326,0±38,4 vs 
108,2±44,7 ng/dl, p <0,05). 
Conclusion 
Chronic hepatitis is a disease with many types, with respect to type B and C have 
aneffect on liver functions, and this phenomenon will affect the serum level of ferritin 
increase in male very high than female and decrease total protein and albumin level 
nearly of the same value in both male and female. Therefore, the development of disease 
and management of drugs and others can be followed can be followed easily.                           
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